Anti-Human LOXL2 Therapeutic Antibody (Simtuzumab)
Recombinant humanized antibody expressed in CHO binding to human LOXL2. Simtuzumab is a humanized monoclonal antibody designed for the treatment of fibrosis. It binds to LOXL2 and acts as an immunomodulator.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-890 |
| Pricing | Inquiry |
| Host | undefined |
| Target | LOXL2 |
| Species Reactivity | Human |
| Type | IgG4 - kappa |
| Applications | Inhib, Agonist |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |